Dahl salt-resistant rats are protected against angiotensin II-induced hypertension. 2022

Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea; Cardiovascular Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea; BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.

Angiotensin II is a potent endogenous vasoconstrictor that induces oxidative stress in hypertensive rodent models. Dahl salt-resistant (SR) rats are protected against hypertension after high salt or high fructose intake. However, whether these rats are also protected against angiotensin II-mediated hypertension has not been investigated. Dahl salt-sensitive (SS) and SR rats were infused with angiotensin II (10 or 50 ng/kg/min) or vehicle via a mini-osmotic pump for 2 weeks. Blood pressure was measured using the tail-cuff method. Paraffin sections of the thoracic aortas and kidneys were stained using hematoxylin/eosin or Masson trichrome. Renal gene expression was measured using reverse transcription-quantitative polymerase chain reaction. Angiotensin II (50 ng/kg/min) induced hypertension in SS rats, but not in SR rats, although low doses of angiotensin II (10 ng/kg/min) transiently increased blood pressure in SS rats. Angiotensin II (50 ng/kg/min) did not induce morphological changes in the aortic walls or kidneys. Angiotensin II (50 ng/kg/min) induced the expression of At1rb, Nox2, Il-17ra, Il-23r, Tgf-β, Il-1β and Il-6 in SS rats, but not in SR rats. In conclusion, SR rats were protected against angiotensin II-induced hypertension. This result implies that the genetic trait that determines salt sensitivity may also determine susceptibility to hypertension in response to vasoconstrictors.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor
D017673 Sodium Chloride, Dietary Sodium chloride used in foods. Dietary Sodium Chloride,Table Salt,Chloride, Dietary Sodium,Salt, Table
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020303 Rats, Inbred Dahl Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion. Dahl Hypertensive Rats,Dahl Rat,Dahl Salt-Resistant Rats,Dahl Salt-Sensitive Rat,Dahl Salt-Sensitive Rats,Dahl Rats,Dahl Rats, Inbred,Dahl Salt Resistant Rats,Dahl Salt Sensitive Rat,Dahl Salt Sensitive Rats,Hypertensive Rats, Dahl,Inbred Dahl Rats,Rat, Dahl,Rat, Dahl Salt-Sensitive,Rats, Dahl,Rats, Dahl Hypertensive,Rats, Dahl Salt-Resistant,Rats, Dahl Salt-Sensitive,Salt-Resistant Rats, Dahl,Salt-Sensitive Rat, Dahl,Salt-Sensitive Rats, Dahl

Related Publications

Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
August 1999, The American journal of physiology,
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
August 2012, Hypertension (Dallas, Tex. : 1979),
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
March 2018, American journal of physiology. Regulatory, integrative and comparative physiology,
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
August 1995, Journal of hypertension,
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
December 1998, Physiology & behavior,
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
July 2021, Journal of the American Heart Association,
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
June 1989, Hypertension (Dallas, Tex. : 1979),
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
June 1991, Hypertension (Dallas, Tex. : 1979),
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
June 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Cheong-Wun Kim, and Jee Young Kim, and Soyung Lee, and Inkyeom Kim
November 2007, British journal of pharmacology,
Copied contents to your clipboard!